Agostini’s Ltd has changed its name to Agostini Ltd. The name change follows a meeting of its shareholders today.
COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that its Board of Directors has authorized the Company to use approximately $25 million to ...
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...
Africa’s pharmaceutical future is at a critical juncture with developments shedding light on the continent’s reliance on external aid for vaccine access. The Trump administration’s initial freeze on ...
ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...
Musk’s arrival at the social platform has raised questions for users, which includes pharma companies who use Twitter ... after an account using its name and logo sent out a Tweet, which read ...
From Ben Affleck's DunKings to David Beckham and his long-lost twin Dave (played by Matt Damon) and all the pop star ...
We recently compiled a list of the Billionaire Ken Fisher’s Top 10 High Growth Stock Picks. In this article, we are going to ...
In a report released today, Laura Chico from Wedbush maintained a Hold rating on Ultragenyx Pharmaceutical (RARE – Research Report), with a ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says ...
Universe Pharmaceuticals (UPC) announced that the company received a letter from the Nasdaq Stock Market on January 29 notifying the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results